ID   EDA_HUMAN               Reviewed;         391 AA.
AC   Q92838; A0AUZ2; A2A337; B7ZLU2; B7ZLU4; O75910; Q5JS00; Q5JUM7; Q9UP77;
AC   Q9Y6L0; Q9Y6L1; Q9Y6L2; Q9Y6L3; Q9Y6L4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   07-APR-2021, entry version 204.
DE   RecName: Full=Ectodysplasin-A;
DE   AltName: Full=Ectodermal dysplasia protein;
DE            Short=EDA protein;
DE   Contains:
DE     RecName: Full=Ectodysplasin-A, membrane form;
DE   Contains:
DE     RecName: Full=Ectodysplasin-A, secreted form;
GN   Name=EDA; Synonyms=ED1, EDA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE [GENOMIC DNA]
RP   OF 1-132, VARIANTS XHED HIS-61 AND LEU-69, AND FUNCTION.
RC   TISSUE=Sweat gland;
RX   PubMed=8696334; DOI=10.1038/ng0895-409;
RA   Kere J., Srivastava A.K., Montonen O., Zonana J., Thomas N.S.T.,
RA   Ferguson B.M., Munoz F., Morgan D., Clarke A., Baybayan P., Chen E.Y.,
RA   Ezer S., Saarialho-Kere U., la Chapelle A., Schlessinger D.;
RT   "X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by
RT   mutation in a novel transmembrane protein.";
RL   Nat. Genet. 13:409-416(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [GENOMIC DNA]
RP   OF 133-391, AND VARIANTS XHED.
RC   TISSUE=Fetal liver;
RX   PubMed=9683615; DOI=10.1086/301984;
RA   Monreal A.W., Zonana J., Ferguson B.M.;
RT   "Identification of a new splice form of the EDA1 gene permits detection of
RT   nearly all X-linked hypohidrotic ectodermal dysplasia mutations.";
RL   Am. J. Hum. Genet. 63:380-389(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4; 5; 6 AND 7), AND VARIANTS
RP   XHED.
RX   PubMed=9736768; DOI=10.1093/hmg/7.11.1661;
RA   Bayes M., Hartung A.J., Ezer S., Pispa J., Thesleff I., Srivastava A.K.,
RA   Kere J.;
RT   "The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative
RT   splicing and encodes ectodysplasin-A with deletion mutations in collagenous
RT   repeats.";
RL   Hum. Mol. Genet. 7:1661-1669(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 8).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RA   Kobielak K., Kobielak A., Trzciak W.H.;
RT   "Expression of a novel transcript isoform of the EDA gene in human
RT   umbilical cord.";
RL   Eur. J. Hum. Genet. Suppl. 7:104-104(1999).
RN   [7]
RP   FUNCTION, AND RECEPTOR INTERACTION (ISOFORMS 1 AND 3).
RX   PubMed=11039935; DOI=10.1126/science.290.5491.523;
RA   Yan M., Wang L.-C., Hymowitz S.G., Schilbach S., Lee J., Goddard A.,
RA   de Vos A.M., Gao W.-Q., Dixit V.M.;
RT   "Two-amino acid molecular switch in an epithelial morphogen that regulates
RT   binding to two distinct receptors.";
RL   Science 290:523-527(2000).
RN   [8]
RP   PROTEOLYTIC PROCESSING, CHARACTERIZATION OF VARIANT XHED CYS-153, AND
RP   CHARACTERIZATION OF VARIANT HIS-156.
RX   PubMed=11309369; DOI=10.1093/hmg/10.9.953;
RA   Elomaa O., Pulkkinen K., Hannelius U., Mikkola M., Saarialho-Kere U.,
RA   Kere J.;
RT   "Ectodysplasin is released by proteolytic shedding and binds to the EDAR
RT   protein.";
RL   Hum. Mol. Genet. 10:953-962(2001).
RN   [9]
RP   CHARACTERIZATION OF VARIANTS XHED CYS-153; CYS-155; CYS-156; HIS-156 AND
RP   ASN-158, MUTAGENESIS OF ARG-159, AND CLEAVAGE SITE.
RX   PubMed=11416205; DOI=10.1073/pnas.131076098;
RA   Chen Y., Molloy S.S., Thomas L., Gambee J., Baechinger H.P., Ferguson B.M.,
RA   Zonana J., Thomas G., Morris N.P.;
RT   "Mutations within a furin consensus sequence block proteolytic release of
RT   ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7218-7223(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 230-391, AND SUBUNIT.
RX   PubMed=14656435; DOI=10.1016/j.str.2003.11.009;
RA   Hymowitz S.G., Compaan D.M., Yan M., Wallweber H.J., Dixit V.M.,
RA   Starovasnik M.A., de Vos A.M.;
RT   "The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct
RT   receptor specificity.";
RL   Structure 11:1513-1520(2003).
RN   [11]
RP   VARIANT XHED TYR-54.
RX   PubMed=9630076; DOI=10.1111/j.1399-0004.1998.tb02678.x;
RA   Hertz J.M., Noergaard Hansen K., Juncker I., Kjeldsen M., Gregersen N.;
RT   "A novel missense mutation (402C-->T) in exon 1 in the EDA gene in a family
RT   with X-linked hypohidrotic ectodermal dysplasia.";
RL   Clin. Genet. 53:205-209(1998).
RN   [12]
RP   VARIANT XHED LYS-63.
RX   PubMed=9507389; DOI=10.1136/jmg.35.2.112;
RA   Ferguson B.M., Thomas N.S.T., Munoz F., Morgan D., Clarke A., Zonana J.;
RT   "Scarcity of mutations detected in families with X linked hypohidrotic
RT   ectodermal dysplasia: diagnostic implications.";
RL   J. Med. Genet. 35:112-115(1998).
RN   [13]
RP   VARIANT XHED ARG-55.
RX   PubMed=10469321; DOI=10.1046/j.1523-1747.1999.00656.x;
RA   Martinez F., Millan J.M., Orellana C., Prieto F.;
RT   "X-linked anhidrotic (hypohidrotic) ectodermal dysplasia caused by a novel
RT   mutation in EDA1 gene: 406T > G (Leu55Arg).";
RL   J. Invest. Dermatol. 113:285-286(1999).
RN   [14]
RP   VARIANT XHED SER-156.
RX   PubMed=10951256; DOI=10.1046/j.1523-1747.2000.00065-1.x;
RA   Aoki N., Ito K., Tachibana T., Ito M.;
RT   "A novel arginine-->Serine mutation in EDA1 in a Japanese family with X-
RT   linked anhidrotic ectodermal dysplasia.";
RL   J. Invest. Dermatol. 115:329-330(2000).
RN   [15]
RP   VARIANTS XHED THR-349 AND ASN-360.
RX   PubMed=11343303; DOI=10.1002/ajmg.1225;
RA   Kobielak K., Kobielak A., Roszkiewicz J., Wierzba J., Limon J.,
RA   Trzeciak W.H.;
RT   "Mutations in the EDA gene in three unrelated families reveal no apparent
RT   correlation between phenotype and genotype in the patients with an X-linked
RT   anhidrotic ectodermal dysplasia.";
RL   Am. J. Med. Genet. 100:191-197(2001).
RN   [16]
RP   VARIANTS XHED ARG-60; TYR-252; VAL-269; SER-302 AND MET-378.
RX   PubMed=11378824; DOI=10.1038/sj.ejhg.5200635;
RA   Vincent M.-C., Biancalana V., Ginisty D., Mandel J.-L., Calvas P.;
RT   "Mutational spectrum of the ED1 gene in X-linked hypohidrotic ectodermal
RT   dysplasia.";
RL   Eur. J. Hum. Genet. 9:355-363(2001).
RN   [17]
RP   VARIANTS XHED CYS-156; HIS-156; CYS-255; ASP-255; GLY-274; TYR-332 AND
RP   THR-349.
RX   PubMed=11295832; DOI=10.1002/humu.33;
RA   Paeaekkoenen K., Cambiaghi S., Novelli G., Ouzts L.V., Penttinen M.,
RA   Kere J., Srivastava A.K.;
RT   "The mutation spectrum of the EDA gene in X-linked anhidrotic ectodermal
RT   dysplasia.";
RL   Hum. Mutat. 17:349-349(2001).
RN   [18]
RP   VARIANTS XHED CYS-153; CYS-155; CYS-156; HIS-156; ASN-158; 183-GLY--PRO-194
RP   DEL; 185-ASN--PRO-196 DEL; GLU-189; 191-PRO--PRO-196 DEL; ARG-207; ASP-218;
RP   218-GLY--PRO-223 DEL; ARG-291; SER-299; CYS-320; CYS-343; ARG-374; PRO-378
RP   AND MET-378.
RX   PubMed=11279189; DOI=10.1074/jbc.m101280200;
RA   Schneider P., Street S.L., Gaide O., Hertig S., Tardivel A., Tschopp J.,
RA   Runkel L., Alevizopoulos K., Ferguson B.M., Zonana J.;
RT   "Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect
RT   three major functional domains in the tumor necrosis factor family member
RT   ectodysplasin-A.";
RL   J. Biol. Chem. 276:18819-18827(2001).
RN   [19]
RP   VARIANTS XHED ALA-198 AND MET-378.
RX   PubMed=12225002; DOI=10.1001/archderm.138.9.1256;
RA   Vincent M.-C., Cossee M., Vabres P., Stewart F., Bonneau D., Calvas P.;
RT   "Pitfalls in clinical diagnosis of female carriers of X-linked hypohidrotic
RT   ectodermal dysplasia.";
RL   Arch. Dermatol. 138:1256-1258(2002).
RN   [20]
RP   VARIANT XHED HIS-306.
RX   PubMed=12932274; DOI=10.1046/j.1365-2133.2003.05480.x;
RA   Hsu M.M.L., Chao S.C., Lu A.C.H.;
RT   "A novel missense mutation (Gln306His) in exon 7 of the ED1 gene causing
RT   anhidrotic ectodermal dysplasia with prominent milia-like facial sebaceous
RT   papules.";
RL   Br. J. Dermatol. 149:443-445(2003).
RN   [21]
RP   INVOLVEMENT IN STHAGX1, AND VARIANT STHAGX1 GLY-65.
RX   PubMed=16583127; DOI=10.1007/s10038-006-0389-2;
RA   Tao R., Jin B., Guo S.Z., Qing W., Feng G.Y., Brooks D.G., Liu L., Xu J.,
RA   Li T., Yan Y., He L.;
RT   "A novel missense mutation of the EDA gene in a Mongolian family with
RT   congenital hypodontia.";
RL   J. Hum. Genet. 51:498-502(2006).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-118.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [23]
RP   VARIANT XHED GLU-358.
RX   PubMed=17256800; DOI=10.1002/ajmg.a.31567;
RA   Tarpey P., Pemberton T.J., Stockton D.W., Das P., Ninis V., Edkins S.,
RA   Andrew Futreal P., Wooster R., Kamath S., Nayak R., Stratton M.R.,
RA   Patel P.I.;
RT   "A novel Gln358Glu mutation in ectodysplasin A associated with X-linked
RT   dominant incisor hypodontia.";
RL   Am. J. Med. Genet. A 143:390-394(2007).
RN   [24]
RP   VARIANTS XHED CYS-155; CYS-156; HIS-156; 183-GLY--PRO-194 DEL;
RP   184-PRO--GLY-189 DEL; 185-ASN--PRO-196 DEL; ARG-291; TYR-298; GLY-307;
RP   ASP-372 AND ILE-373.
RX   PubMed=18231121; DOI=10.1038/sj.ejhg.5202012;
RA   van der Hout A.H., Oudesluijs G.G., Venema A., Verheij J.B.G.M.,
RA   Mol B.G.J., Rump P., Brunner H.G., Vos Y.J., van Essen A.J.;
RT   "Mutation screening of the ectodysplasin-A receptor gene EDAR in
RT   hypohidrotic ectodermal dysplasia.";
RL   Eur. J. Hum. Genet. 16:673-679(2008).
RN   [25]
RP   VARIANT STHAGX1 MET-338.
RX   PubMed=18657636; DOI=10.1016/j.ejmg.2008.06.002;
RA   Han D., Gong Y., Wu H., Zhang X., Yan M., Wang X., Qu H., Feng H., Song S.;
RT   "Novel EDA mutation resulting in X-linked non-syndromic hypodontia and the
RT   pattern of EDA-associated isolated tooth agenesis.";
RL   Eur. J. Med. Genet. 51:536-546(2008).
RN   [26]
RP   VARIANTS XHED CYS-153; CYS-155 AND THR-349.
RX   PubMed=19438931; DOI=10.1111/j.1399-0004.2009.01178.x;
RA   Shimomura Y., Wajid M., Weiser J., Kraemer L., Ishii Y., Lombillo V.,
RA   Bale S.J., Christiano A.M.;
RT   "Identification of mutations in the EDA and EDAR genes in Pakistani
RT   families with hypohidrotic ectodermal dysplasia.";
RL   Clin. Genet. 75:582-584(2009).
RN   [27]
RP   VARIANTS STHAGX1 GLU-259; CYS-289 AND HIS-334.
RX   PubMed=19278982; DOI=10.1177/0022034508328627;
RA   Song S., Han D., Qu H., Gong Y., Wu H., Zhang X., Zhong N., Feng H.;
RT   "EDA gene mutations underlie non-syndromic oligodontia.";
RL   J. Dent. Res. 88:126-131(2009).
RN   [28]
RP   VARIANT XHED ARG-381.
RX   PubMed=19127222; DOI=10.1203/pdr.0b013e3181991229;
RA   Gunadi X., Miura K., Ohta M., Sugano A., Lee M.J., Sato Y., Matsunaga A.,
RA   Hayashi K., Horikawa T., Miki K., Wataya-Kaneda M., Katayama I.,
RA   Nishigori C., Matsuo M., Takaoka Y., Nishio H.;
RT   "Two novel mutations in the ED1 gene in Japanese families with X-linked
RT   hypohidrotic ectodermal dysplasia.";
RL   Pediatr. Res. 65:453-457(2009).
RN   [29]
RP   VARIANT XHED CYS-155.
RX   PubMed=20486090; DOI=10.4238/vol9-2gmr810;
RA   Khabour O.F., Mesmar F.S., Al-Tamimi F., Al-Batayneh O.B., Owais A.I.;
RT   "Missense mutation of the EDA gene in a Jordanian family with X-linked
RT   hypohidrotic ectodermal dysplasia: phenotypic appearance and speech
RT   problems.";
RL   Genet. Mol. Res. 9:941-948(2010).
RN   [30]
RP   VARIANTS XHED GLY-156; 192-GLY--GLN-197 DEL; VAL-207; ARG-211; ARG-266;
RP   ARG-274; PRO-293; VAL-296; ASP-299; GLY-323; TYR-346 AND VAL-356.
RX   PubMed=20979233; DOI=10.1002/humu.21384;
RA   Cluzeau C., Hadj-Rabia S., Jambou M., Mansour S., Guigue P., Masmoudi S.,
RA   Bal E., Chassaing N., Vincent M.C., Viot G., Clauss F., Maniere M.C.,
RA   Toupenay S., Le Merrer M., Lyonnet S., Cormier-Daire V., Amiel J.,
RA   Faivre L., de Prost Y., Munnich A., Bonnefont J.P., Bodemer C., Smahi A.;
RT   "Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of
RT   hypohidrotic/anhidrotic ectodermal dysplasia cases.";
RL   Hum. Mutat. 32:70-72(2011).
RN   [31]
RP   VARIANT XHED PRO-354.
RX   PubMed=22008666; DOI=10.1016/j.gene.2011.10.009;
RA   Liu Y., Yu X., Wang L., Li C., Archacki S., Huang C., Liu J.Y., Wang Q.,
RA   Liu M., Tang Z.;
RT   "Mutation p.Leu354Pro in EDA causes severe hypohidrotic ectodermal
RT   dysplasia in a Chinese family.";
RL   Gene 491:246-250(2012).
RN   [32]
RP   VARIANT XHED ARG-319.
RX   PubMed=22350046;
RA   Piccione M., Serra G., Sanfilippo C., Andreucci E., Sani I., Corsello G.;
RT   "A new mutation in EDA gene in X-linked hypohidrotic ectodermal dysplasia
RT   associated with keratoconus.";
RL   Minerva Pediatr. 64:59-64(2012).
RN   [33]
RP   VARIANT STHAGX1 SER-260.
RX   PubMed=23625373; DOI=10.1177/0022034513487557;
RA   Yang Y., Luo L., Xu J., Zhu P., Xue W., Wang J., Li W., Wang M., Cheng K.,
RA   Liu S., Tang Z., Ring B.Z., Su L.;
RT   "Novel EDA p.Ile260Ser mutation linked to non-syndromic hypodontia.";
RL   J. Dent. Res. 92:500-506(2013).
RN   [34]
RP   INVOLVEMENT IN STHAGX1.
RX   PubMed=23603338; DOI=10.1177/0022034513487210;
RA   Nikopensius T., Annilo T., Jagomaegi T., Gilissen C., Kals M.,
RA   Krjutskov K., Maegi R., Eelmets M., Gerst-Talas U., Remm M., Saag M.,
RA   Hoischen A., Metspalu A.;
RT   "Non-syndromic tooth agenesis associated with a nonsense mutation in
RT   ectodysplasin-A (EDA).";
RL   J. Dent. Res. 92:507-511(2013).
RN   [35]
RP   VARIANTS STHAGX1 LEU-289 AND VAL-379.
RX   PubMed=24487376; DOI=10.1177/0022034514522059;
RA   Lee K.E., Ko J., Shin T.J., Hyun H.K., Lee S.H., Kim J.W.;
RT   "Oligodontia and curly hair occur with ectodysplasin-a mutations.";
RL   J. Dent. Res. 93:371-375(2014).
RN   [36]
RP   VARIANTS XHED GLN-51; CYS-125; PRO-132; HIS-153; CYS-155; HIS-156;
RP   183-GLY--PRO-194 DEL; 185-ASN--PRO-196 DEL; 191-PRO--PRO-196 DEL;
RP   193-PRO--GLY-201 DEL; 219-PRO--GLY-230 DEL; GLY-274; ARG-291; SER-299;
RP   HIS-304; GLU-316; ARG-319; SER-319 DEL; PHE-332; ASP-350; HIS-358 AND
RP   VAL-381.
RX   PubMed=24724966; DOI=10.1111/cge.12404;
RA   Guazzarotti L., Tadini G., Mancini G.E., Giglio S., Willoughby C.E.,
RA   Callea M., Sani I., Nannini P., Mameli C., Tenconi A.A., Mauri S.,
RA   Bottero A., Caimi A., Morelli M., Zuccotti G.V.;
RT   "Phenotypic heterogeneity and mutational spectrum in a cohort of 45 Italian
RT   males subjects with X-linked ectodermal dysplasia.";
RL   Clin. Genet. 87:338-342(2015).
RN   [37]
RP   VARIANTS XHED CYS-155; ASP-221; SER-299 AND MET-338.
RX   PubMed=27657131; DOI=10.3390/genes7090065;
RA   Zeng B., Xiao X., Li S., Lu H., Lu J., Zhu L., Yu D., Zhao W.;
RT   "Eight mutations of three genes (EDA, EDAR, and WNT10A) identified in seven
RT   hypohidrotic ectodermal dysplasia patients.";
RL   Genes (Basel) 7:0-0(2016).
RN   [38]
RP   CHARACTERIZATION OF VARIANTS XHED LEU-252; CYS-343 AND ARG-374,
RP   CHARACTERIZATION OF VARIANTS STHAGX1 GLU-259; CYS-289; HIS-334; CYS-343 AND
RP   ARG-374, AND FUNCTION.
RX   PubMed=27144394; DOI=10.1371/journal.pone.0154884;
RA   Shen W., Wang Y., Liu Y., Liu H., Zhao H., Zhang G., Snead M.L., Han D.,
RA   Feng H.;
RT   "Functional study of ectodysplasin-a mutations causing non-syndromic tooth
RT   agenesis.";
RL   PLoS ONE 11:E0154884-E0154884(2016).
CC   -!- FUNCTION: Cytokine which is involved in epithelial-mesenchymal
CC       signaling during morphogenesis of ectodermal organs. Functions as a
CC       ligand activating the DEATH-domain containing receptors EDAR and EDA2R
CC       (PubMed:8696334, PubMed:11039935, PubMed:27144394). May also play a
CC       role in cell adhesion (By similarity). {ECO:0000250|UniProtKB:O54693,
CC       ECO:0000269|PubMed:11039935, ECO:0000269|PubMed:27144394,
CC       ECO:0000269|PubMed:8696334}.
CC   -!- FUNCTION: [Isoform 1]: Binds only to the receptor EDAR, while isoform 3
CC       binds exclusively to the receptor EDA2R. {ECO:0000269|PubMed:11039935,
CC       ECO:0000269|PubMed:27144394}.
CC   -!- FUNCTION: [Isoform 3]: Binds only to the receptor EDA2R.
CC       {ECO:0000269|PubMed:11039935, ECO:0000269|PubMed:27144394}.
CC   -!- SUBUNIT: Homotrimer. The homotrimers may then dimerize and form higher-
CC       order oligomers. {ECO:0000269|PubMed:14656435}.
CC   -!- INTERACTION:
CC       Q92838; P27449: ATP6V0C; NbExp=4; IntAct=EBI-529425, EBI-721179;
CC       Q92838; Q4LDR2: CTXN3; NbExp=3; IntAct=EBI-529425, EBI-12019274;
CC       Q92838; P49447: CYB561; NbExp=6; IntAct=EBI-529425, EBI-8646596;
CC       Q92838; Q9UPQ8: DOLK; NbExp=6; IntAct=EBI-529425, EBI-8645574;
CC       Q92838; P54849: EMP1; NbExp=3; IntAct=EBI-529425, EBI-4319440;
CC       Q92838; P54852: EMP3; NbExp=7; IntAct=EBI-529425, EBI-3907816;
CC       Q92838; Q96F15: GIMAP5; NbExp=6; IntAct=EBI-529425, EBI-6166686;
CC       Q92838; O95214: LEPROTL1; NbExp=4; IntAct=EBI-529425, EBI-750776;
CC       Q92838; Q6FHL7: LEPROTL1; NbExp=3; IntAct=EBI-529425, EBI-10249700;
CC       Q92838; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-529425, EBI-12033434;
CC       Q92838; P21145: MAL; NbExp=7; IntAct=EBI-529425, EBI-3932027;
CC       Q92838; Q5J8X5: MS4A13; NbExp=3; IntAct=EBI-529425, EBI-12070086;
CC       Q92838; Q6P499: NIPAL3; NbExp=8; IntAct=EBI-529425, EBI-10252783;
CC       Q92838; Q9NRP0: OSTC; NbExp=3; IntAct=EBI-529425, EBI-1044658;
CC       Q92838; Q8TBU1: OSTCL; NbExp=3; IntAct=EBI-529425, EBI-10273677;
CC       Q92838; P26678: PLN; NbExp=11; IntAct=EBI-529425, EBI-692836;
CC       Q92838; Q01453: PMP22; NbExp=3; IntAct=EBI-529425, EBI-2845982;
CC       Q92838; Q96IW7: SEC22A; NbExp=7; IntAct=EBI-529425, EBI-8652744;
CC       Q92838; Q9NVC3: SLC38A7; NbExp=3; IntAct=EBI-529425, EBI-10314552;
CC       Q92838; Q69YG0: TMEM42; NbExp=3; IntAct=EBI-529425, EBI-12038591;
CC       Q92838; P56557: TMEM50B; NbExp=3; IntAct=EBI-529425, EBI-12366453;
CC       Q92838; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-529425, EBI-2852148;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O54693};
CC       Single-pass type II membrane protein {ECO:0000250|UniProtKB:O54693}.
CC   -!- SUBCELLULAR LOCATION: [Ectodysplasin-A, secreted form]: Secreted
CC       {ECO:0000269|PubMed:11309369}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=A1, II, EDA1 {ECO:0000303|PubMed:27144394};
CC         IsoId=Q92838-1; Sequence=Displayed;
CC       Name=2; Synonyms=I;
CC         IsoId=Q92838-2; Sequence=VSP_006454, VSP_006455;
CC       Name=3; Synonyms=A2, EDA2 {ECO:0000303|PubMed:27144394};
CC         IsoId=Q92838-3; Sequence=VSP_006464;
CC       Name=4; Synonyms=C;
CC         IsoId=Q92838-5; Sequence=VSP_006458, VSP_006461;
CC       Name=5; Synonyms=D;
CC         IsoId=Q92838-6; Sequence=VSP_006456, VSP_006457;
CC       Name=6; Synonyms=E;
CC         IsoId=Q92838-7; Sequence=VSP_006459, VSP_006461;
CC       Name=7; Synonyms=F;
CC         IsoId=Q92838-8; Sequence=VSP_006460, VSP_006461;
CC       Name=8;
CC         IsoId=Q92838-9; Sequence=VSP_038402, VSP_006464;
CC   -!- TISSUE SPECIFICITY: Not abundant; expressed in specific cell types of
CC       ectodermal (but not mesodermal) origin of keratinocytes, hair
CC       follicles, sweat glands. Also in adult heart, liver, muscle, pancreas,
CC       prostate, fetal liver, uterus, small intestine and umbilical chord.
CC       {ECO:0000269|Ref.6}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:O54693}.
CC   -!- PTM: Processing by furin produces a secreted form.
CC       {ECO:0000269|PubMed:11416205}.
CC   -!- DISEASE: Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED)
CC       [MIM:305100]: A form of ectodermal dysplasia, a heterogeneous group of
CC       disorders due to abnormal development of two or more ectodermal
CC       structures. Characterized by sparse hair (atrichosis or hypotrichosis),
CC       abnormal or missing teeth and the inability to sweat due to the absence
CC       of sweat glands. It is the most common form of over 150 clinically
CC       distinct ectodermal dysplasias. {ECO:0000269|PubMed:10469321,
CC       ECO:0000269|PubMed:10951256, ECO:0000269|PubMed:11279189,
CC       ECO:0000269|PubMed:11295832, ECO:0000269|PubMed:11309369,
CC       ECO:0000269|PubMed:11343303, ECO:0000269|PubMed:11378824,
CC       ECO:0000269|PubMed:11416205, ECO:0000269|PubMed:12225002,
CC       ECO:0000269|PubMed:12932274, ECO:0000269|PubMed:17256800,
CC       ECO:0000269|PubMed:18231121, ECO:0000269|PubMed:19127222,
CC       ECO:0000269|PubMed:19438931, ECO:0000269|PubMed:20486090,
CC       ECO:0000269|PubMed:20979233, ECO:0000269|PubMed:22008666,
CC       ECO:0000269|PubMed:22350046, ECO:0000269|PubMed:24724966,
CC       ECO:0000269|PubMed:27144394, ECO:0000269|PubMed:27657131,
CC       ECO:0000269|PubMed:8696334, ECO:0000269|PubMed:9507389,
CC       ECO:0000269|PubMed:9630076, ECO:0000269|PubMed:9683615,
CC       ECO:0000269|PubMed:9736768}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500]:
CC       A form of selective tooth agenesis, a common anomaly characterized by
CC       the congenital absence of one or more teeth. Selective tooth agenesis
CC       without associated systemic disorders has sometimes been divided into 2
CC       types: oligodontia, defined as agenesis of 6 or more permanent teeth,
CC       and hypodontia, defined as agenesis of less than 6 teeth. The number in
CC       both cases does not include absence of third molars (wisdom teeth).
CC       {ECO:0000269|PubMed:16583127, ECO:0000269|PubMed:18657636,
CC       ECO:0000269|PubMed:19278982, ECO:0000269|PubMed:23603338,
CC       ECO:0000269|PubMed:23625373, ECO:0000269|PubMed:24487376,
CC       ECO:0000269|PubMed:27144394}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 5]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the tumor necrosis factor family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC77372.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U59227; AAC50678.1; -; Genomic_DNA.
DR   EMBL; U59228; AAC50679.1; -; mRNA.
DR   EMBL; AH006445; AAC36303.1; -; Genomic_DNA.
DR   EMBL; AF060999; AAC36302.1; -; mRNA.
DR   EMBL; AF040628; AAC77363.1; -; mRNA.
DR   EMBL; AF061189; AAC77371.1; -; mRNA.
DR   EMBL; AF061190; AAC77372.1; ALT_SEQ; mRNA.
DR   EMBL; AF061191; AAC77373.1; -; mRNA.
DR   EMBL; AF061192; AAC77374.1; -; mRNA.
DR   EMBL; AF061193; AAC77375.1; -; mRNA.
DR   EMBL; AF061194; AAC77376.1; -; mRNA.
DR   EMBL; AL158069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FO393403; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126143; AAI26144.1; -; mRNA.
DR   EMBL; BC144049; AAI44050.1; -; mRNA.
DR   EMBL; BC144051; AAI44052.1; -; mRNA.
DR   CCDS; CCDS14394.1; -. [Q92838-1]
DR   CCDS; CCDS35318.2; -. [Q92838-2]
DR   CCDS; CCDS35319.2; -. [Q92838-9]
DR   CCDS; CCDS43966.1; -. [Q92838-3]
DR   CCDS; CCDS55436.1; -. [Q92838-7]
DR   RefSeq; NP_001005609.1; NM_001005609.1. [Q92838-3]
DR   RefSeq; NP_001005610.2; NM_001005610.3. [Q92838-2]
DR   RefSeq; NP_001005612.2; NM_001005612.2. [Q92838-9]
DR   RefSeq; NP_001005613.1; NM_001005613.3. [Q92838-7]
DR   RefSeq; NP_001390.1; NM_001399.4. [Q92838-1]
DR   PDB; 1RJ7; X-ray; 2.30 A; A/B/D/E/F/G/H/I/J/K/L/M=233-391.
DR   PDB; 1RJ8; X-ray; 2.23 A; A/B/D/E/F/G=230-389.
DR   PDBsum; 1RJ7; -.
DR   PDBsum; 1RJ8; -.
DR   SMR; Q92838; -.
DR   BioGRID; 108224; 95.
DR   IntAct; Q92838; 71.
DR   STRING; 9606.ENSP00000363680; -.
DR   GlyGen; Q92838; 2 sites.
DR   iPTMnet; Q92838; -.
DR   PhosphoSitePlus; Q92838; -.
DR   BioMuta; EDA; -.
DR   DMDM; 6166135; -.
DR   MassIVE; Q92838; -.
DR   PaxDb; Q92838; -.
DR   PeptideAtlas; Q92838; -.
DR   PRIDE; Q92838; -.
DR   ProteomicsDB; 75522; -. [Q92838-1]
DR   ProteomicsDB; 75523; -. [Q92838-2]
DR   ProteomicsDB; 75524; -. [Q92838-3]
DR   ProteomicsDB; 75525; -. [Q92838-5]
DR   ProteomicsDB; 75526; -. [Q92838-6]
DR   ProteomicsDB; 75527; -. [Q92838-7]
DR   ProteomicsDB; 75528; -. [Q92838-8]
DR   ProteomicsDB; 75529; -. [Q92838-9]
DR   ABCD; Q92838; 3 sequenced antibodies.
DR   Antibodypedia; 27342; 556 antibodies.
DR   Ensembl; ENST00000338901; ENSP00000340611; ENSG00000158813. [Q92838-5]
DR   Ensembl; ENST00000374552; ENSP00000363680; ENSG00000158813. [Q92838-1]
DR   Ensembl; ENST00000374553; ENSP00000363681; ENSG00000158813. [Q92838-3]
DR   Ensembl; ENST00000524573; ENSP00000432585; ENSG00000158813. [Q92838-9]
DR   Ensembl; ENST00000525810; ENSP00000434195; ENSG00000158813. [Q92838-2]
DR   Ensembl; ENST00000527388; ENSP00000434861; ENSG00000158813. [Q92838-7]
DR   GeneID; 1896; -.
DR   KEGG; hsa:1896; -.
DR   UCSC; uc004dxm.2; human. [Q92838-1]
DR   CTD; 1896; -.
DR   DisGeNET; 1896; -.
DR   GeneCards; EDA; -.
DR   GeneReviews; EDA; -.
DR   HGNC; HGNC:3157; EDA.
DR   HPA; ENSG00000158813; Low tissue specificity.
DR   MalaCards; EDA; -.
DR   MIM; 300451; gene.
DR   MIM; 305100; phenotype.
DR   MIM; 313500; phenotype.
DR   neXtProt; NX_Q92838; -.
DR   OpenTargets; ENSG00000158813; -.
DR   Orphanet; 2227; NON RARE IN EUROPE: Hypodontia.
DR   Orphanet; 99798; Oligodontia.
DR   Orphanet; 181; X-linked hypohidrotic ectodermal dysplasia.
DR   PharmGKB; PA27601; -.
DR   VEuPathDB; HostDB:ENSG00000158813.17; -.
DR   eggNOG; ENOG502QUAV; Eukaryota.
DR   GeneTree; ENSGT00730000111220; -.
DR   HOGENOM; CLU_1880065_0_0_1; -.
DR   InParanoid; Q92838; -.
DR   OMA; AGPRENQ; -.
DR   OrthoDB; 1183050at2759; -.
DR   PhylomeDB; Q92838; -.
DR   TreeFam; TF332099; -.
DR   PathwayCommons; Q92838; -.
DR   Reactome; R-HSA-5669034; TNFs bind their physiological receptors. [Q92838-3]
DR   SIGNOR; Q92838; -.
DR   BioGRID-ORCS; 1896; 6 hits in 621 CRISPR screens.
DR   ChiTaRS; EDA; human.
DR   EvolutionaryTrace; Q92838; -.
DR   GeneWiki; EDA_(gene); -.
DR   GenomeRNAi; 1896; -.
DR   Pharos; Q92838; Tbio.
DR   PRO; PR:Q92838; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q92838; protein.
DR   Bgee; ENSG00000158813; Expressed in frontal cortex and 152 other tissues.
DR   ExpressionAtlas; Q92838; baseline and differential.
DR   Genevisible; Q92838; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005811; C:lipid droplet; IDA:HPA.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0038177; F:death receptor agonist activity; IMP:UniProtKB.
DR   GO; GO:0005123; F:death receptor binding; IDA:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IDA:HGNC-UCL.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:InterPro.
DR   GO; GO:0048513; P:animal organ development; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0060789; P:hair follicle placode formation; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:UniProtKB.
DR   GO; GO:0043473; P:pigmentation; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:HGNC-UCL.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:1901222; P:regulation of NIK/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0060662; P:salivary gland cavitation; IEA:Ensembl.
DR   GO; GO:0061153; P:trachea gland development; IEA:Ensembl.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR006052; TNF_dom.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00229; TNF; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50049; TNF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Cleavage on pair of basic residues; Collagen; Developmental protein;
KW   Differentiation; Disease variant; Ectodermal dysplasia; Glycoprotein;
KW   Membrane; Reference proteome; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..391
FT                   /note="Ectodysplasin-A, membrane form"
FT                   /id="PRO_0000034538"
FT   CHAIN           160..391
FT                   /note="Ectodysplasin-A, secreted form"
FT                   /evidence="ECO:0000305|PubMed:11416205"
FT                   /id="PRO_0000034539"
FT   TOPO_DOM        1..41
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        42..62
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        63..391
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          180..229
FT                   /note="Collagen-like"
FT   SITE            159..160
FT                   /note="Cleavage; by furin"
FT                   /evidence="ECO:0000269|PubMed:11416205"
FT   CARBOHYD        313
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         133..147
FT                   /note="MALLNFFFPDEKPYS -> VSHLVGAAAAPSPRG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006458"
FT   VAR_SEQ         133..147
FT                   /note="MALLNFFFPDEKPYS -> DFDYIISFSYGLQGFC (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006459"
FT   VAR_SEQ         133..147
FT                   /note="MALLNFFFPDEKPYS -> LHVSFSLRKKKAGHQ (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006460"
FT   VAR_SEQ         133..142
FT                   /note="MALLNFFFPD -> ACFPQVLLSL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006456"
FT   VAR_SEQ         133..135
FT                   /note="MAL -> GHQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8696334"
FT                   /id="VSP_006454"
FT   VAR_SEQ         136..391
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8696334"
FT                   /id="VSP_006455"
FT   VAR_SEQ         143..391
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006457"
FT   VAR_SEQ         148..391
FT                   /note="Missing (in isoform 4, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006461"
FT   VAR_SEQ         265..267
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038402"
FT   VAR_SEQ         307..308
FT                   /note="Missing (in isoform 3 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9736768"
FT                   /id="VSP_006464"
FT   VARIANT         51
FT                   /note="L -> Q (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075310"
FT   VARIANT         54
FT                   /note="H -> Y (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:9630076"
FT                   /id="VAR_010611"
FT   VARIANT         55
FT                   /note="L -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:10469321"
FT                   /id="VAR_010612"
FT   VARIANT         60
FT                   /note="C -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11378824"
FT                   /id="VAR_013484"
FT   VARIANT         61
FT                   /note="Y -> H (in XHED; dbSNP:rs132630308)"
FT                   /evidence="ECO:0000269|PubMed:8696334"
FT                   /id="VAR_005179"
FT   VARIANT         63
FT                   /note="E -> K (in XHED; dbSNP:rs132630311)"
FT                   /evidence="ECO:0000269|PubMed:9507389"
FT                   /id="VAR_005180"
FT   VARIANT         65
FT                   /note="R -> G (in STHAGX1; dbSNP:rs132630319)"
FT                   /evidence="ECO:0000269|PubMed:16583127"
FT                   /id="VAR_029534"
FT   VARIANT         69
FT                   /note="R -> L (in XHED; dbSNP:rs132630309)"
FT                   /evidence="ECO:0000269|PubMed:8696334"
FT                   /id="VAR_005181"
FT   VARIANT         118
FT                   /note="P -> L (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036590"
FT   VARIANT         125
FT                   /note="S -> C (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075311"
FT   VARIANT         132
FT                   /note="Q -> P (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075312"
FT   VARIANT         153
FT                   /note="R -> C (in XHED; abolishes proteolytic processing;
FT                   dbSNP:rs397516662)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11309369, ECO:0000269|PubMed:11416205,
FT                   ECO:0000269|PubMed:19438931"
FT                   /id="VAR_054454"
FT   VARIANT         153
FT                   /note="R -> H (in XHED; unknown pathological significance;
FT                   dbSNP:rs140642493)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075313"
FT   VARIANT         155
FT                   /note="R -> C (in XHED; abolishes proteolytic processing;
FT                   dbSNP:rs132630312)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11416205, ECO:0000269|PubMed:18231121,
FT                   ECO:0000269|PubMed:19438931, ECO:0000269|PubMed:20486090,
FT                   ECO:0000269|PubMed:24724966, ECO:0000269|PubMed:27657131,
FT                   ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005182"
FT   VARIANT         156
FT                   /note="R -> C (in XHED; abolishes proteolytic processing;
FT                   dbSNP:rs132630313)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11295832, ECO:0000269|PubMed:11416205,
FT                   ECO:0000269|PubMed:18231121, ECO:0000269|PubMed:9683615,
FT                   ECO:0000269|PubMed:9736768"
FT                   /id="VAR_005183"
FT   VARIANT         156
FT                   /note="R -> G (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064858"
FT   VARIANT         156
FT                   /note="R -> H (in XHED; abolishes proteolytic processing;
FT                   dbSNP:rs132630314)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11295832, ECO:0000269|PubMed:11309369,
FT                   ECO:0000269|PubMed:11416205, ECO:0000269|PubMed:18231121,
FT                   ECO:0000269|PubMed:24724966, ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005184"
FT   VARIANT         156
FT                   /note="R -> S (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:10951256"
FT                   /id="VAR_054455"
FT   VARIANT         158
FT                   /note="K -> N (in XHED; abolishes proteolytic processing;
FT                   dbSNP:rs727504649)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11416205"
FT                   /id="VAR_054456"
FT   VARIANT         183..194
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:18231121, ECO:0000269|PubMed:24724966"
FT                   /id="VAR_054457"
FT   VARIANT         184..189
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054458"
FT   VARIANT         185..196
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:18231121, ECO:0000269|PubMed:24724966"
FT                   /id="VAR_054459"
FT   VARIANT         189
FT                   /note="G -> E (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054460"
FT   VARIANT         191..196
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:24724966"
FT                   /id="VAR_054461"
FT   VARIANT         192..197
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064859"
FT   VARIANT         193..201
FT                   /note="Missing (in XHED; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075314"
FT   VARIANT         198
FT                   /note="G -> A (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:12225002"
FT                   /id="VAR_054462"
FT   VARIANT         207
FT                   /note="G -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054463"
FT   VARIANT         207
FT                   /note="G -> V (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064860"
FT   VARIANT         209
FT                   /note="P -> L (in XHED; dbSNP:rs132630315)"
FT                   /evidence="ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005185"
FT   VARIANT         211
FT                   /note="T -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064861"
FT   VARIANT         218..223
FT                   /note="Missing (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054465"
FT   VARIANT         218
FT                   /note="G -> D (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054464"
FT   VARIANT         219..230
FT                   /note="Missing (in XHED; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075315"
FT   VARIANT         221
FT                   /note="G -> D (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:27657131"
FT                   /id="VAR_077561"
FT   VARIANT         224
FT                   /note="G -> A (in XHED; dbSNP:rs132630316)"
FT                   /evidence="ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005186"
FT   VARIANT         252
FT                   /note="H -> L (in XHED; loss of interaction with EDAR for
FT                   isoform 1; decreased interaction with EDA2R for isoform 3;
FT                   changed downstream signaling; dbSNP:rs879255552)"
FT                   /evidence="ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005187"
FT   VARIANT         252
FT                   /note="H -> Y (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11378824"
FT                   /id="VAR_013485"
FT   VARIANT         255
FT                   /note="G -> C (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11295832"
FT                   /id="VAR_011077"
FT   VARIANT         255
FT                   /note="G -> D (in XHED; mild; dbSNP:rs1064793105)"
FT                   /evidence="ECO:0000269|PubMed:11295832"
FT                   /id="VAR_011078"
FT   VARIANT         259
FT                   /note="A -> E (in STHAGX1; decreased interaction with EDAR
FT                   for isoform 1; decreased interaction with EDA2R for isoform
FT                   3; changed downstream signaling; dbSNP:rs879255611)"
FT                   /evidence="ECO:0000269|PubMed:19278982"
FT                   /id="VAR_071454"
FT   VARIANT         260
FT                   /note="I -> S (in STHAGX1)"
FT                   /evidence="ECO:0000269|PubMed:23625373"
FT                   /id="VAR_071455"
FT   VARIANT         266
FT                   /note="L -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064862"
FT   VARIANT         269
FT                   /note="G -> V (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11378824"
FT                   /id="VAR_013486"
FT   VARIANT         274
FT                   /note="W -> G (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11295832,
FT                   ECO:0000269|PubMed:24724966"
FT                   /id="VAR_011079"
FT   VARIANT         274
FT                   /note="W -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064863"
FT   VARIANT         289
FT                   /note="R -> C (in STHAGX1; decreased interaction with EDAR
FT                   for isoform 1; decreased interaction with EDA2R for isoform
FT                   3; changed downstream signaling; dbSNP:rs879255551)"
FT                   /evidence="ECO:0000269|PubMed:19278982"
FT                   /id="VAR_071456"
FT   VARIANT         289
FT                   /note="R -> L (in STHAGX1)"
FT                   /evidence="ECO:0000269|PubMed:24487376"
FT                   /id="VAR_071457"
FT   VARIANT         291
FT                   /note="G -> R (in XHED; dbSNP:rs397516677)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:18231121, ECO:0000269|PubMed:24724966,
FT                   ECO:0000269|PubMed:9736768"
FT                   /id="VAR_010613"
FT   VARIANT         291
FT                   /note="G -> W (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:9736768"
FT                   /id="VAR_010614"
FT   VARIANT         293
FT                   /note="L -> P (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064864"
FT   VARIANT         296
FT                   /note="L -> V (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064865"
FT   VARIANT         298
FT                   /note="D -> H (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:9736768"
FT                   /id="VAR_010615"
FT   VARIANT         298
FT                   /note="D -> Y (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054466"
FT   VARIANT         299
FT                   /note="G -> D (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064866"
FT   VARIANT         299
FT                   /note="G -> S (in XHED; dbSNP:rs397516679)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:24724966, ECO:0000269|PubMed:27657131,
FT                   ECO:0000269|PubMed:9683615, ECO:0000269|PubMed:9736768"
FT                   /id="VAR_005188"
FT   VARIANT         302
FT                   /note="F -> S (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11378824"
FT                   /id="VAR_013487"
FT   VARIANT         304
FT                   /note="Y -> H (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075316"
FT   VARIANT         306
FT                   /note="Q -> H (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:12932274"
FT                   /id="VAR_054467"
FT   VARIANT         307
FT                   /note="V -> G (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054468"
FT   VARIANT         316
FT                   /note="D -> E (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075317"
FT   VARIANT         319
FT                   /note="S -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:22350046,
FT                   ECO:0000269|PubMed:24724966"
FT                   /id="VAR_067319"
FT   VARIANT         320
FT                   /note="Y -> C (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054469"
FT   VARIANT         323
FT                   /note="V -> G (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064867"
FT   VARIANT         332
FT                   /note="C -> F (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075318"
FT   VARIANT         332
FT                   /note="C -> Y (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11295832"
FT                   /id="VAR_011080"
FT   VARIANT         334
FT                   /note="R -> H (in STHAGX1; decreased interaction with EDAR
FT                   for isoform 1; decreased interaction with EDA2R for isoform
FT                   3; changed downstream signaling; dbSNP:rs142948132)"
FT                   /evidence="ECO:0000269|PubMed:19278982"
FT                   /id="VAR_071458"
FT   VARIANT         338
FT                   /note="T -> M (in STHAGX1 and XHED; dbSNP:rs132630321)"
FT                   /evidence="ECO:0000269|PubMed:18657636,
FT                   ECO:0000269|PubMed:27657131"
FT                   /id="VAR_064868"
FT   VARIANT         343
FT                   /note="Y -> C (in XHED; loss of interaction with EDAR for
FT                   isoform 1; decreased interaction with EDA2R for isoform 3;
FT                   changed downstream signaling)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054470"
FT   VARIANT         346
FT                   /note="C -> Y (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064869"
FT   VARIANT         349
FT                   /note="A -> T (in XHED; dbSNP:rs132630317)"
FT                   /evidence="ECO:0000269|PubMed:11295832,
FT                   ECO:0000269|PubMed:11343303, ECO:0000269|PubMed:19438931,
FT                   ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005189"
FT   VARIANT         350
FT                   /note="G -> D (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075319"
FT   VARIANT         354
FT                   /note="L -> P (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:22008666"
FT                   /id="VAR_067250"
FT   VARIANT         356
FT                   /note="A -> D (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005190"
FT   VARIANT         356
FT                   /note="A -> V (in XHED; dbSNP:rs876657639)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064870"
FT   VARIANT         357
FT                   /note="R -> P (in XHED; dbSNP:rs61747506)"
FT                   /evidence="ECO:0000269|PubMed:9683615"
FT                   /id="VAR_005191"
FT   VARIANT         358
FT                   /note="Q -> E (in XHED; dbSNP:rs132630320)"
FT                   /evidence="ECO:0000269|PubMed:17256800"
FT                   /id="VAR_054471"
FT   VARIANT         358
FT                   /note="Q -> H (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075320"
FT   VARIANT         360
FT                   /note="I -> N (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11343303"
FT                   /id="VAR_054472"
FT   VARIANT         372
FT                   /note="N -> D (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054473"
FT   VARIANT         373
FT                   /note="M -> I (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054474"
FT   VARIANT         374
FT                   /note="S -> R (in XHED; decreased interaction with EDAR for
FT                   isoform 1; decreased interaction with EDA2R for isoform 3;
FT                   changed downstream signaling)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054475"
FT   VARIANT         378
FT                   /note="T -> M (in XHED; dbSNP:rs1569407346)"
FT                   /evidence="ECO:0000269|PubMed:11279189,
FT                   ECO:0000269|PubMed:11378824, ECO:0000269|PubMed:12225002"
FT                   /id="VAR_013488"
FT   VARIANT         378
FT                   /note="T -> P (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:11279189"
FT                   /id="VAR_054476"
FT   VARIANT         379
FT                   /note="F -> V (in STHAGX1)"
FT                   /evidence="ECO:0000269|PubMed:24487376"
FT                   /id="VAR_071459"
FT   VARIANT         381
FT                   /note="G -> R (in XHED)"
FT                   /evidence="ECO:0000269|PubMed:19127222"
FT                   /id="VAR_064871"
FT   VARIANT         381
FT                   /note="G -> V (in XHED; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24724966"
FT                   /id="VAR_075321"
FT   MUTAGEN         159
FT                   /note="R->A: Abolishes proteolytic processing."
FT                   /evidence="ECO:0000269|PubMed:11416205"
FT   STRAND          249..254
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          257..261
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   HELIX           262..264
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   HELIX           266..269
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          275..279
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   TURN            281..283
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          284..286
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   TURN            288..290
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          293..295
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          299..307
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          310..316
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          318..324
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          327..336
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          338..340
FT                   /evidence="ECO:0007744|PDB:1RJ7"
FT   STRAND          342..354
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          359..364
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          370..372
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   TURN            375..377
FT                   /evidence="ECO:0007744|PDB:1RJ8"
FT   STRAND          378..386
FT                   /evidence="ECO:0007744|PDB:1RJ8"
SQ   SEQUENCE   391 AA;  41294 MW;  15DB3F5053293CBA CRC64;
     MGYPEVERRE LLPAAAPRER GSQGCGCGGA PARAGEGNSC LLFLGFFGLS LALHLLTLCC
     YLELRSELRR ERGAESRLGG SGTPGTSGTL SSLGGLDPDS PITSHLGQPS PKQQPLEPGE
     AALHSDSQDG HQMALLNFFF PDEKPYSEEE SRRVRRNKRS KSNEGADGPV KNKKKGKKAG
     PPGPNGPPGP PGPPGPQGPP GIPGIPGIPG TTVMGPPGPP GPPGPQGPPG LQGPSGAADK
     AGTRENQPAV VHLQGQGSAI QVKNDLSGGV LNDWSRITMN PKVFKLHPRS GELEVLVDGT
     YFIYSQVEVY YINFTDFASY EVVVDEKPFL QCTRSIETGK TNYNTCYTAG VCLLKARQKI
     AVKMVHADIS INMSKHTTFF GAIRLGEAPA S
//
